Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)

NCT04443348 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer
Hormone Receptor Positive (HR+), HER2-negative Breast Cancer
Biopsy-proven, Positive Lymph Node(s)

Interventions

RADIATION: Radiation Therapy Boost
DRUG: Pembrolizumab
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Capecitabine

Sponsor

Laura M. Spring, MD

Collaborators

[object Object]
[object Object]
[object Object]